• 29 November, 2025

PPP: A push for affordable healthcare

February 04, 2011 | Friday | News


In the second part of this series that decodes the success of PPPs and its prospects, BioSpectrum showcases three case studies that exemplify the benefits of such partnerships

Development of innovative technologies to facilitate research in 3D Cell Culture for Regenerative Medicine and Tissue Engineering by Hyderabad-based ExCel Matrix Biological Devices.

Bhubneshwar-based Imgenex India's initiatives on developing drugs against osteoporosis using the applications of nanobiotechnology.


New Delhi-based ARA Healthcare's projects to carry out pre-clinical and phase I clinical development of three recombinant proteins, ARA-I, ARA-II, and ARA-III.


Mission: Creating novel tissue engineering techniques

Mission: Tackling osteoporosis using nanobiotech

Mission: Fighting cancer with recombinant

Comments

× Your session has expired. Please click here to Sign-in or Sign-up
New User? Create Account

Trending Topics

Most Read

Survey Box

Is India’s clinical research landscape entering a new phase?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy